195 related articles for article (PubMed ID: 15508792)
1. [Cardiopulmonary exercise testing and cytokines in chronic heart failure. Comparison of patients with ischaemic and with dilated cardiomyopathy].
Straburzyńska-Migaj E; Leśniewska K; Ochotny R; Straburyńska-Lupa A; Baszko A; Wiktorowicz K; Cieśliński A
Pol Arch Med Wewn; 2004 Jun; 111(6):693-701. PubMed ID: 15508792
[TBL] [Abstract][Full Text] [Related]
2. Cytokines and heart rate variability in patients with chronic heart failure.
Straburzyńska-Migaj E; Ochotny R; Wachowiak-Baszyńska A; Straburzyńska-Lupa A; Leśniewska K; Wiktorowicz K; Cieśliński A
Kardiol Pol; 2005 Nov; 63(5):478-85; discussion 486-7. PubMed ID: 16362851
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone administration reduces circulating proinflammatory cytokines and soluble Fas/soluble Fas ligand system in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy.
Adamopoulos S; Parissis JT; Georgiadis M; Karatzas D; Paraskevaidis J; Kroupis C; Karavolias G; Koniavitou K; Kremastinos DT
Am Heart J; 2002 Aug; 144(2):359-64. PubMed ID: 12177657
[TBL] [Abstract][Full Text] [Related]
4. Restrictive filling pattern is associated with increased humoral activation and impaired exercise capacity in dilated cardiomyopathy.
Patrianakos AP; Parthenakis FI; Papadimitriou EA; Diakakis GF; Tzerakis PG; Nikitovic D; Vardas PE
Eur J Heart Fail; 2004 Oct; 6(6):735-43. PubMed ID: 15542409
[TBL] [Abstract][Full Text] [Related]
5. Effects of growth hormone on circulating cytokine network, and left ventricular contractile performance and geometry in patients with idiopathic dilated cardiomyopathy.
Adamopoulos S; Parissis JT; Paraskevaidis I; Karatzas D; Livanis E; Georgiadis M; Karavolias G; Mitropoulos D; Degiannis D; Kremastinos DT
Eur Heart J; 2003 Dec; 24(24):2186-96. PubMed ID: 14659770
[TBL] [Abstract][Full Text] [Related]
6. Myocardial cytokine gene expression is higher in aortic stenosis than in idiopathic dilated cardiomyopathy.
Vanderheyden M; Paulus WJ; Voss M; Knuefermann P; Sivasubramanian N; Mann D; Baumgarten G
Heart; 2005 Jul; 91(7):926-31. PubMed ID: 15958363
[TBL] [Abstract][Full Text] [Related]
7. Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure.
Adamopoulos S; Parissis J; Karatzas D; Kroupis C; Georgiadis M; Karavolias G; Paraskevaidis J; Koniavitou K; Coats AJ; Kremastinos DT
J Am Coll Cardiol; 2002 Feb; 39(4):653-63. PubMed ID: 11849865
[TBL] [Abstract][Full Text] [Related]
8. [Cytokines and remodeling of the heart in patients with congestive heart failure].
Jołda-Mydłowska B; Salomon P
Pol Arch Med Wewn; 2003 Jan; 109(1):23-33. PubMed ID: 12879763
[TBL] [Abstract][Full Text] [Related]
9. [Activation and role of the tumor necrosis factor-alpha in congestive heart failure].
Bachetti T; Comini L; Agnoletti L; Gaia G; Milanesi B; Curello S; Corti A; Ferrari R; Visioli O
Cardiologia; 1996 Apr; 41(4):343-7. PubMed ID: 8674103
[TBL] [Abstract][Full Text] [Related]
10. Increase of plasma IL-9 and decrease of plasma IL-5, IL-7, and IFN-γ in patients with chronic heart failure.
Cappuzzello C; Di Vito L; Melchionna R; Melillo G; Silvestri L; Cesareo E; Crea F; Liuzzo G; Facchiano A; Capogrossi MC; Napolitano M
J Transl Med; 2011 Mar; 9():28. PubMed ID: 21418620
[TBL] [Abstract][Full Text] [Related]
11. Proinflammatory cytokine activation is linked to apoptotic mediator, soluble Fas level in patients with chronic heart failure.
Kinugawa T; Kato M; Yamamoto K; Hisatome I; Nohara R
Int Heart J; 2012; 53(3):182-6. PubMed ID: 22790687
[TBL] [Abstract][Full Text] [Related]
12. Circulating levels of cytokines and their site of production in patients with mild to severe chronic heart failure.
Petretta M; Condorelli GL; Spinelli L; Scopacasa F; de Caterina M; Leosco D; Vicario ML; Bonaduce D
Am Heart J; 2000 Dec; 140(6):E28. PubMed ID: 11100001
[TBL] [Abstract][Full Text] [Related]
13. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Aukrust P; Ueland T; Lien E; Bendtzen K; Müller F; Andreassen AK; Nordøy I; Aass H; Espevik T; Simonsen S; Frøland SS; Gullestad L
Am J Cardiol; 1999 Feb; 83(3):376-82. PubMed ID: 10072227
[TBL] [Abstract][Full Text] [Related]
14. [Tumor necrosis factor receptors sTNF-RI and sTNF-RII in advanced chronic heart failure].
Nowak J; Rozentryt P; Szewczyk M; Gierlotka M; Duszańska A; Szyguła B; Wojnicz R; Hawranek M; Poloński L; Zembala M
Pol Arch Med Wewn; 2002 Mar; 107(3):223-9. PubMed ID: 12107980
[TBL] [Abstract][Full Text] [Related]
15. Elevated plasma amylase levels in advanced chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy: correlation with circulating interleukin-6 activity.
Parissis JT; Adamopoulos SN; Venetsanou KF; Karas SM; Kremastinos DT
J Interferon Cytokine Res; 2003 Jun; 23(6):329-33. PubMed ID: 12859859
[TBL] [Abstract][Full Text] [Related]
16. Immune activation is associated with reduced skeletal muscle mass and physical function in chronic heart failure.
Toth MJ; Ades PA; Tischler MD; Tracy RP; LeWinter MM
Int J Cardiol; 2006 May; 109(2):179-87. PubMed ID: 16024109
[TBL] [Abstract][Full Text] [Related]
17. [Cardiopulmonary stress test in patients with heart failure and atrial fibrillation].
Nessler J; Nessler B; Stopyra K; Gajos G; Piwowarska W
Kardiol Pol; 2004 Sep; 61 Suppl 2():II76-81. PubMed ID: 20527422
[TBL] [Abstract][Full Text] [Related]
18. Decrease of circulating myeloid dendritic cells in patients with chronic heart failure.
Pistulli R; Hammer N; Rohm I; Kretzschmar D; Jung C; Figulla HR; Yilmaz A
Acta Cardiol; 2016 Apr; 71(2):165-72. PubMed ID: 27090038
[TBL] [Abstract][Full Text] [Related]
19. Endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathy.
Tentolouris C; Tousoulis D; Antoniades C; Bosinakou E; Kotsopoulou M; Trikas A; Toutouzas P; Stefanadis C
Int J Cardiol; 2004 Apr; 94(2-3):301-5. PubMed ID: 15093997
[TBL] [Abstract][Full Text] [Related]
20. Atrial fibrillation is associated with increased neurohumoral activation and reduced exercise tolerance in patients with non-ischemic dilated cardiomyopathy.
Parthenakis FI; Patrianakos AP; Skalidis EI; Diakakis GF; Zacharis EA; Chlouverakis G; Karalis IK; Vardas PE
Int J Cardiol; 2007 May; 118(2):206-14. PubMed ID: 17027102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
